'''Perafensine''' ([[International Nonproprietary Name|INN]]) (code name '''HR-459''') is a [[drug]] which was investigated as an [[antidepressant]] but was never marketed.<ref name="GanellinTriggle1996">{{cite book|author1=C.R. Ganellin|author2=David J. Triggle|title=Dictionary of Pharmacological Agents|url=https://books.google.com/books?id=A0THacd46ZsC&pg=PA1585|date=21 November 1996|publisher=CRC Press|isbn=978-0-412-46630-4|pages=1585–}}</ref> It has been reported to antagonize the effects of [[reserpine]] and to [[reuptake inhibitor|inhibit]] the [[reuptake]] of [[norepinephrine]] ([[norepinephrine reuptake inhibitor]]); whether it also affects the reuptake of [[serotonin]] or [[dopamine]] is unclear.<ref name="BondinellKaiser1982">{{cite journal|last1=Bondinell|first1=WilliamE.|last2=Kaiser|first2=Carl|title=Chapter 5. Antidepressants|volume=17|year=1982|pages=41–50|issn=0065-7743|doi=10.1016/S0065-7743(08)60487-X}}</ref>
